Market Place
Sourcing Support
Phispers: Pfizer-Allergan end megamerger, GSK wants to make copying its drugs easier & more
This week, the
biggest news in the world of pharmaceuticals was the termination of the Pfizer-Allerg
Niche European Molecules: is there a business opportunity worth pursuing?
New drug development is a series of complex
activities invariably involving tremendous financial in
